Dendreon Corp fka DNDNQ

[anon13333]

First, this the opening bid to put BP on notice.

This is just for Provenge and other certain assets.

Pursuant to the terms of the agreement, Valeant will acquire the world-wide rights to Dendreon's PROVENGE(R) (sipuleucel-T) product and certain other Dendreon assets.

What about other assets (e.g. the current phase III trial candidate) and other assets? They are worth something.

Also,

From PR:
Valeant will acquire the world-wide rights to Dendreon's PROVENGE® (sipuleucel-T) product and certain other Dendreon assets.

From docket 282:
Total Assets: $ 342,783 is not part of the deal.

VRX offer is 342M+296M=638M.

Anything more belong to shareholder.

Check the document and bring in your thoughts.